High-Intensity Laser Therapy vs Epidural Injection for Chronic Lumbar Disc Herniation Pain
Official title: Comparison of the Effectiveness of High-Intensity Laser Therapy and Transforaminal Epidural Steroid Injection in Patients With Chronic Axial and Radicular Low Back Pain Due to Lumbar Disc Herniation: A Prospective Randomized Controlled Trial
Run by Ankara City Hospital Bilkent · NCT07688915 · Data updated 2026-11-12
This trial tests whether high-intensity laser therapy can relieve chronic low back and leg pain as well as a transforaminal epidural steroid injection in adults with lumbar disc herniation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | Ankara City Hospital Bilkent Academic / other |
| Locations | 1 site (Ankara) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | October 1, 2026 |
| Study ends | October 1, 2026 |
| Registry record updated | July 7, 2026 |
| Trial ID | NCT07688915 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with chronic lumbar disc herniation causing axial and radicular pain for more than 3 months and a resting pain score of ≥5 on the VAS.
✕Probably not a fit
Patients whose pain is primarily non-radicular, who have had prior spinal surgery, or who do not respond to home exercise may see little to no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this randomized, single-blind study, adults with chronic axial and radicular pain due to lumbar disc herniation are assigned to either high-intensity laser therapy (HILT) or fluoroscopy-guided transforaminal epidural steroid injection (TFESI), with all participants also following a home-based exercise program. Pain intensity on the Visual Analog Scale is the primary outcome, measured at baseline, 2 weeks, 6 weeks, and 12 weeks; secondary outcomes include functional disability, neuropathic pain symptoms, quality of life, and walking capacity. The trial aims to determine which intervention provides better pain relief and functional improvement over 12 weeks. Participants attend 15 HILT sessions over 3 weeks or receive a TFESI procedure, with eligibility limited to adults 18–65 years old who have imaging-confirmed lumbar disc herniation and chronic symptoms lasting more than 3 months. The study is conducted at Ankara City Hospital Bilkent and affiliated centers in Ankara, Turkey.
Why it matters
Potential benefit: If successful, participants may experience greater pain relief and improved function with a non-invasive laser therapy option comparable to an established injection therapy.
How similar studies have gone: Prior research has shown benefit from both modalities in related conditions, but head-to-head data in chronic lumbar disc herniation are limited, making this a relatively novel comparison.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 65 years * Diagnosis of lumbar disc herniation confirmed by clinical examination and lumbar magnetic resonance imaging * Chronic axial low back pain and radicular pain related to lumbar disc herniation * Low back and/or radicular pain lasting longer than 3 months * Resting low back and/or radicular pain intensity of ≥5 on a 0-10 visual analog scale * Willingness to participate in the study and provide written informed consent Exclusion Criteria: * Pregnancy or suspected pregnancy * Presence of a cardiac pacemaker * History of epilepsy * Active or previous malignancy * History of spinal surgery * Uncontrolled systemic or psychiatric disease * Cauda equina syndrome or progressive neurological deficit * Peripheral neuropathy, including diabetic or alcohol-related neuropathy * Neurodegenerative disease * Acute trauma * Active systemic infection * Local infection or skin disease at the injection site or treatment area * Body mass index greater than 40 kg/m² * Bleeding disorder that contraindicates treatment * Spinal stenosis, spondylolysis, or spondylolisthesis * Neurogenic bladder or bowel syndrome * Rheumatologic disease * Arterial vascular disease or vascular claudication * Receipt of other physical therapy modalities within the last 3 months * Receipt of spinal injection therapy within the last 3 months * History of allergy to injection agents
Where it's running
-
Ankara Bilkent City Hospital, Physical Medicine and Rehabilitation Hospital
Ankara, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Esra Ülgen Kıratlıoğlu, MD
- Email: esraulgen@gmail.com
- Phone: +905079614194
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using regional anesthesia to reduce opioid use in spine surgery
This study is testing if a special pain management technique can help people having spine surgery use less opioid medication after their operation.
-
Predicting success of epidural injections for sciatica treatment
This study is trying to find out which factors can help predict how well epidural injections will work for people with sciatica caused by a herniated disc or spinal stenosis.
-
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Type 2 Diabetes
This trial tests whether an ultrasound-guided injection into the thoracolumbar fascia, added to standard care, helps reduce chronic low back pain in adults with type 2 diabetes.
-
Mulligan leg raise vs spinal mobilization with leg movement for lumbar radiculopathy
This trial tests whether Mulligan leg raise traction or spinal mobilization with leg movement helps people with lumbar radiculopathy feel better.
-
Prone lumbar disc surgery: how breathing and brain oxygen relate
This study will observe whether changes in breathing mechanics during prone lumbar disc surgery relate to brain oxygen levels in adults.
-
Subcutaneous Fat, Back Muscles, and Spine Shape in Back Pain Patients
This study tests whether body fat under the skin and features of back muscles and spine joints are linked to lumbar facet joint degeneration in adults with chronic low back pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.